Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases

Arch Dermatol. 1998 Jun;134(6):700-2. doi: 10.1001/archderm.134.6.700.

Abstract

Background: Human herpesvirus 8 (HHV-8) has been detected in all epidemiological forms of Kaposi sarcoma (KS). The role of HHV-8 in dermatologic diseases other than KS is controversial. Some studies based on polymerase chain reaction findings suggest an association between HHV-8 and epithelial tumors of the skin, lymphoproliferative disorders, or pemphigus.

Objective: To assess the prevalence of antibodies against a latent nuclear antigen of HHV-8 in patients with various dermatologic diseases.

Design: An indirect immunofluorescence assay was used to search for HHV-8 antibodies.

Setting: Ambulatory or hospitalized patients from a university hospital associated with a research laboratory.

Patients: Eighty-three patients with various non-KS dermatologic diseases and 16 patients with KS who were seronegative for the human immunodeficiency virus. Controls were 100 healthy subjects living in the same area.

Results: Antibodies to HHV-8 were found in 100% (16/16) of the patients with KS and 3.6% (3/83) of the patients with non-KS dermatologic diseases: 1 patient with pemphigus vulgaris, 1 with discoid lupus erythematosus, and 1 with bullous pemphigoid. The prevalence of antibodies to HHV-8 in controls was 2% (2/100) and was not significantly different than the prevalence in patients with dermatologic diseases other than KS (P =.28).

Conclusions: Our serologic study confirms the higher prevalence of HHV-8 antibodies in patients with KS and demonstrates that contrary to other human herpesviruses, HHV-8 is not a ubiquitous virus in France. We could not determine any causal association between HHV-8 and pemphigus or lymphoproliferative disorders of the skin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, Nuclear
  • Autoantigens / blood*
  • Biomarkers / blood*
  • DNA-Binding Proteins / blood
  • Female
  • Fluorescent Antibody Technique, Indirect
  • France
  • Herpesviridae Infections / diagnosis*
  • Herpesviridae Infections / immunology
  • Herpesviridae Infections / virology*
  • Herpesvirus 8, Human / isolation & purification*
  • Humans
  • Lupus Erythematosus, Cutaneous / virology
  • Nuclear Proteins / blood*
  • Pemphigoid, Bullous / virology
  • Pemphigus / virology
  • Prevalence
  • Sarcoma, Kaposi / virology
  • Skin Diseases / immunology
  • Skin Diseases / virology*
  • Skin Neoplasms / virology

Substances

  • Antigens, Nuclear
  • Autoantigens
  • Biomarkers
  • DNA-Binding Proteins
  • Nuclear Proteins